Replies to post #31143 on Biotech Values

[iwfal]

Everything DNDN has done to date is consistent with the intention to defer the completion of the BLA until the 9902b efficacy data are in hand.

So you will admit error on this if they file by end of 2006?

My personal speculation is that they are waiting for P-11. If P-11 is a complete bust they may well choose not to file.